Dreman Value Management’s AbbVie ABBV Stock Holding History

Dreman Value Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.99M	Sell	21,065 -1,355	-6%	-$149K	0.9%	15
2017 Q4	$2.17M	Sell	22,420 -1,082	-5%	-$102K	1.22%	13
2017 Q3	$2.09M	Sell	23,502 -1,656	-7%	-$126K	1.14%	14
2017 Q2	$1.82M	Buy	25,158 +2,802	+13%	+$188K	1%	21
2017 Q1	$1.46M	Sell	22,356 -552	-2%	-$34.7K	0.83%	29
2016 Q4	$1.44M	Buy	22,908 +7,889	+53%	+$482K	0.8%	27
2016 Q3	$947K	Sell	15,019 -878	-6%	-$56.8K	0.58%	62
2016 Q2	$984K	Sell	15,897 -14,645	-48%	-$892K	0.61%	57
2016 Q1	$1.75M	Buy	30,542 +4,275	+16%	+$238K	0.2%	136
2015 Q4	$1.56M	Sell	26,267 -4,930	-16%	-$284K	0.47%	57
2015 Q3	$1.7M	Buy	31,197 +2,905	+10%	+$189K	0.17%	148
2015 Q2	$1.9M	Buy	28,292 +18,637	+193%	+$1.22M	0.16%	186
2015 Q1	$565K	Buy	+9,655	New	+$583K	0.05%	241
2014 Q1	–	Sell	-4,572	Closed	-$241K	–	419
2013 Q4	$241K	Buy	+4,572	New	+$225K	0.02%	248

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dreman Value Management's ABBV Position: Q1 2018 in Review

Dreman Value Management reduced its AbbVie (ABBV) stake by 6% in Q1 2018, selling an estimated $149K and leaving 21,065 shares worth $1.99M. The position accounts for 0.9% of the portfolio, ranked #15.

Dreman Value Management first reported a position in ABBV in Q4 2013 and has held it in 14 quarters since. The position peaked at $2.17M in Q4 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Dreman Value Management held 21,065 shares of AbbVie worth $1.99M as of Q1 2018.
Dreman Value Management sold 1,355 AbbVie shares in Q1 2018, an estimated $149K.
AbbVie made up 0.9% of Dreman Value Management's portfolio in Q1 2018, its #15 holding.
Dreman Value Management first reported a position in AbbVie in Q4 2013 and has held it in 14 quarters since.
Dreman Value Management's AbbVie position peaked at $2.17M in Q4 2017.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.